Atezolizumab and bevacizumab in the treatment of hepatocellular carcinoma

Abstract

Very positive treatment results with the combination of atezolizumab-bevacizumab led to the inclusion among the first-line treatment options of ESMO guidelines for the treatment of advanced hepatocellular cancer.

Keywords

• atezolizumab
• bevacizumab
• liver cancer
• hepatocellular carcinoma